NOAELTAXEL - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Image for trademark with serial number 79290127
Serial Number
79290127
Word Mark
NOAELTAXEL
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2021-05-04
Filing Date
2020-06-16
Mark Drawing
4000 - Standard character mark Typeset
Law Office Assigned Location Code
M20
Employee Name
SEVERSON, JUSTIN
Statements
Goods and Services
Medicines for the treatment of gastrointestinal diseases; injectable mineral solutions for medical purposes; antioxidants for medical purposes; haematogen; pharmaceutical preparations for tumor treatment; multivitamin preparations; suppositories; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for diagnosis; sedatives; analgesics; vaginal washes for medical purposes; pharmaceutical preparations for treating asthma; medicines for dental purposes; haemorrhoid preparations; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; vaccines against pneumococcal infections; dermatological pharmaceutical products; contraceptive preparations; antihypertensives; anti-uric preparations; anti-diabetic pharmaceuticals; pharmaceutical preparations for anus; antibiotic preparations; antibiotics; anti-cancer preparations; anti-cancer treatment supplements; antidepressants; anticoagulants; antineoplastics; anti-dermoinfectives; antidotes; antipyretic analgesics; febrifuges; vasoconstrictors; hypoglycemic agents; blood thinners; pharmaceutical preparations for respiratory organs; respiratory stimulants; Pharmaceutical preparations; pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; tonics [medicines]; oral contraceptive pills; antiemetics; local anesthetics; bronchodilating preparations; anti-cough drops; androgen preparations; pituitary hormone preparations; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; vaccines against flu; chilblain preparations; pharmaceutical preparations for headache; anaesthetics; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for immunity adjustment; nutritive substances for microorganisms; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations for urogenital organs; vitamin preparations; pharmaceutical products for the treatment of bone diseases; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; nervines; ophthalmic preparations; allergy medications; chemico-pharmaceutical preparations; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical products for treating respiratory diseases and asthma; mixed vitamin preparations; preparations for the treatment of burns; disinfectants for chemical toilets; chemotherapeutics; preparations for treatment of hepatitis; preparations for treating colds; preparations for the treatment of hyperlipidemia; preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of osteoporosis; preparations for the treatment of osteoporosis; injectable pharmaceuticals for treatment of anaphylactic reactions; pharmaceutical preparations for treating halitosis; nausea treatment preparations; antiulcerants; pharmaceutical preparations for the treatment of musculoskeletal disorders; preparations for the treatment of muscle fatigue; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for the treatment of dandruff; pharmaceutical preparations for the treatment of rhinitis; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; pharmaceutical preparations for the treatment of cells; medicines for treating intestinal disorders; cardiovascular treatment preparations; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for treating allergies; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; medicated mouth treatment preparations; transdermal patches for medical treatment; pharmaceutical preparations for the treatment of gout; drug delivery agents; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-07-24
Primary Code
005
Correspondences
Name
MYUNG, Jung Yong
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1542200
International Registration Date
2020-06-16
International Publication Date
2020-07-23
International Renewal Date
2030-06-16
Auto Protection Date
2022-01-23
International Status
001 - Request for extension of protection established
International Status Date
2020-07-23
Priority Claimed In
True
Priority Claimed Date
2020-06-15
First Refusal In
True
Trademark Events
Event DateEvent Description
2020-07-23SN ASSIGNED FOR SECT 66A APPL FROM IB
2020-07-24NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-07-28APPLICATION FILING RECEIPT MAILED
2020-09-18ASSIGNED TO EXAMINER
2020-09-23NON-FINAL ACTION WRITTEN
2020-09-24NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2020-10-19REFUSAL PROCESSED BY MPU
2020-10-19NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2020-11-08REFUSAL PROCESSED BY IB
2021-05-04ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
2021-05-04ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
2021-09-03NEW REPRESENTATIVE AT IB RECEIVED
2021-12-29NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
2021-12-29NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2022-01-15NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB